Label: information for the user
Protopic 0.03% ointment
tacrolimus monohydrate
Read this label carefully before starting to use this medicine, as it contains important information for you.
Contents ofthe label:
The active ingredient of Protopic, tacrolimus monohydrate, is an immunomodulator agent.
Protopic 0.03% ointment is used to treat moderate to severe atopic dermatitis (eczema) in adults who do not respond adequately or are intolerant to conventional therapies such as topical corticosteroids, and in children (2 years of age and older) who failed to obtain an adequate response to conventional therapies such as topical corticosteroids.
Once moderate to severe atopic dermatitis disappears or almost disappears after up to 6 weeks of treatment of a flare-up, and if you experience frequent flares (i.e., 4 or more per year), you can prevent them from recurring or prolong the time free of flares by using Protopic 0.03% ointment twice a week.
In atopic dermatitis, excessive skin reaction of the immune system causes skin inflammation (pruritus, redness, dryness). Protopic modifies the abnormal immune response and relieves skin inflammation and pruritus.
Do not use Protopic
Warnings and precautions
Consult your doctor before starting to use Protopic:
Children
Other medications, cosmetics, and Protopic
Inform your doctor or pharmacist if you areusing,haveusedrecentlyor may have to useany other medication.
You can use moisturizing creams and lotions during treatment with Protopic, but not during the two hours before and after applying Protopic.
The use of Protopic at the same time as other topical preparations or simultaneously with oral immunosuppressive medications or corticosteroids (for example, cortisone) has not been studied.
Use of Protopic with alcohol
While using Protopic, consuming alcohol may cause skin redness or flushing and a sensation of heat.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Protopic contains butylhydroxytoluene (E321)
Protopic contains butylhydroxytoluene (E321), which may cause local skin reactions (such as contact dermatitis) or irritation of the eyes and mucous membranes.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Children (2 years of age and older)
Apply Protopic 0.03% ointment twice a day for a maximum of three weeks, once in the morning and once at night. Subsequently, the ointment should be used once a day on each affected skin area until the eczema disappears.
Adults (16 years of age and older)
Two concentrations of Protopic (Protopic 0.03% and Protopic 0.1% ointment) are available for adult patients (16 years of age and older). Your doctor will decide which concentration is most suitable for you.
Typically, treatment begins with Protopic 0.1% ointment twice a day, once in the morning and once at night, until the eczema is eliminated. Your doctor will decide whether the frequency of application can be reduced based on your eczema response or if the lower concentration Protopic 0.03% ointment can be used.
Treat each affected skin area until the eczema has disappeared. Improvement is usually seen within a week. If no improvement is seen after two weeks, consult your doctor for other possible treatments.
Your doctor may tell you to use Protopic ointment twice a week once your atopic dermatitis has disappeared or almost disappeared (Protopic 0.03% for children and Protopic 0.1% for adults). Protopic ointment should be applied once a day two times a week (e.g., Monday and Thursday) on the areas of your body that are usually affected by atopic dermatitis. There should be 2-3 days without treatment with Protopic between applications.
If symptoms reappear, use Protopic twice a day as indicated above, and visit your doctor to review your treatment.
If you accidentally ingest something of the ointment
If someone accidentally ingests the ointment, consult your doctor or pharmacist as soon as possible. Do not try to induce vomiting.
If you forgot to use Protopic
If you forget to apply the ointment at the scheduled time, do it as soon as you remember and then continue as before.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication mayproduceadverse effects, although not all people will experience them.
Very frequent (may affect more than 1 in 10 people):
These symptoms are usually mild or moderate and generally disappear within a week of using Protopic.
Frequent (may affect up to 1 in 10 people):
Rare (may affect fewer than 1 in 100 people):
After treatment twice a week, skin infections at the application site have been reported in children and adults. Impetigo, a superficial bacterial skin infection that usually produces blisters or sores, has been reported in children.
Also, rosacea (facial redness), rosacea-type dermatitis, lentigo (flat brown skin patches), edema at the application site, and herpes eye infections have been reported during post-marketing.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through thenational notification system included in theAppendix V. By reporting adverse effects, you can contribute to providing more information about the safety of this medication.
Keepthis medicationout of the sight and reach of children.
Do notusethis medicationafterthe expiration date that appears on the packaging and on the boxafter EXP. The expiration date is the last day of the month indicated.
Do not store at a temperature above25°C.
Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the packaging and medications that you no longer need. In this way, you will help protect the environment.
Composition of Protopic
One gram of Protopic 0.03% ointment contains 0.3mg of tacrolimus (as tacrolimus monohydrate).
Appearance of the product and contents of the package
Protopic is a white or slightly yellowish ointment. It is presented in tubes with 10, 30 or60grams of ointment.Only some package sizes may be commercially available.Protopic is available in two concentrations (Protopic 0.03% and Protopic 0.1% ointment).
Marketing Authorization Holder
LEO Pharma A/S
Industriparken 55
2750 Ballerup
Denmark
Responsible for manufacturing
Astellas Ireland Co. Ltd.
Killorglin
County Kerry
Ireland
LEO Laboratories Ltd.
285 Cashel Road
Crumlin, Dublin 12
Ireland
For more information about this medicine, please contact the local representative of the marketing authorization holder:
Belgium/Belgique/Belgien LEO Pharma N.V./S.A Tel: +32 3 740 7868 | Lithuania Biocodex UAB Tel: +370 37 408 681 |
Bulgaria Borola Ltd Tel: +359 2 9156 136 | Luxembourg/Luxemburg LEO Pharma N.V./S.A Tel: +32 3 740 7868 |
Czech Republic LEO Pharma s.r.o. Tel: +420 225 992 272 | Hungary LEO Pharma Tel: +36 1 888 0525 |
Denmark LEO Pharma AB Tel: +45 70 22 49 11 | Malta E.J. Busuttil Ltd Tel: +356 2144 7184 |
Germany LEO Pharma GmbH Tel: +49 6102 2010 | Netherlands LEO Pharma B.V. Tel: +31 205104141 |
Estonia Biocodex OÜ Tel: +372 6 056 014 | Norway LEO Pharma AS Tel: +47 22514900 |
Greece LEO Pharmaceutical Hellas S.A. Tel: +30 210 68 34322 | Austria LEO Pharma GmbH Tel: +43 1 503 6979 |
Spain Laboratorios LEO Pharma, S.A. Tel: +34 93 221 3366 | Poland LEO Pharma Sp. z o.o. Tel: +48 22 244 18 40 |
France Laboratoires LEO SA Tel: +33 1 3014 40 00 | Portugal LEO Farmacêuticos Lda. Tel: +351 21 711 0760 |
Croatia Remedia d.o.o. Tel: +3851 3778 770 | Romania LEO Pharma A/S Romania Tel: +40 213121963 |
Ireland LEO Laboratories Ltd Tel: +353 1 490 8924 | Slovenia PHARMAGAN d.o.o. Tel: +386 4 2366 700 |
Iceland Vistor hf. Tel: +354 535 7000 | Slovakia LEO Pharma s.r.o. Tel: +421 2 5939 6236 |
Italy LEO Pharma S.p.A. Tel: +39 06 52625500 | Finland/Suomi LEO Pharma Oy Tel: +358 20 721 8440 |
Cyprus The Star Medicines Importers Co. Ltd. Tel: +357 2537 1056 | Sweden LEO Pharma AB Tel: +46 40 3522 00 |
Lithuania Biocodex SIA Tel: +371 6761 9365 | United Kingdom LEO Laboratories Ltd Tel: +44 1844 347333 |
Last update of this leaflet:
The detailed information on this medicine is available on the website of the European Medicines Agency:http://www.ema.europa.eu.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.